Table 2.

Comparison of immune function between the two groups of patients (x̅±s, %)

Indicators	Experimental group		Control group		t	P-value
CD3+	Before treatment	70.26±5.65	Before treatment	70.30±5.40	0.040	0.968
	After treatment	57.65±4.68	After treatment	63.58±5.20	6.566	<0.001
	t	13.314	t	6.943
	P	<0.001	P	<0.001
CD4+	Before treatment	30.98±3.51	Before treatment	31.01±3.20	0.049	0.961
	After treatment	40.98±3.68	After treatment	35.41±3.98	7.959	<0.001
	t	15.231	t	6.674
	P	<0.001	P	<0.001
CD4+/CD8+	Before treatment	1.08±0.12	Before treatment	1.06±0.14	0.840	0.403
	After treatment	1.72±0.23	After treatment	1.42±0.25	6.841	<0.001
	t	19.109	t	9.732
	P	<0.001	P	<0.001